OpenClinical trial: Optional / allowed
Conquer Cancer Career Development Award (CDA)
Conquer Cancer, the ASCO Foundation · Nonprofit
Source: Conquer Cancer, the ASCO Foundation (curated) · View original posting ↗
Annual cycle: current deadline October 8, 2026, for a grant term running July 2027 – July 2030.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $200K
- DeadlineFinal application due date.
- Oct 8, 2026
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- 3 yr
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $200K total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Early careerHigher educationNonprofit
Research areas
Clinical trialsTraining & career development
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Three-year award ($200,000 total, paid $66,666/year) supporting early-career clinical investigators (within their first faculty years) conducting patient-oriented oncology research. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.